Novozymes A/S banner

Novozymes A/S
OTC:NVZMY

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
OTC:NVZMY
Watchlist
Price: 59.08 USD -0.82% Market Closed
Market Cap: $27.4B

P/OCF

39.9
Current
No historical data
Comparison unavailable

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
39.9
=
Market Cap
$165.6B
/
Operating Cash Flow
kr4.2B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
39.9
=
Market Cap
$165.6B
/
Operating Cash Flow
kr4.2B

Valuation Scenarios

Novozymes A/S is trading above its 3-year average

If P/OCF returns to its 3-Year Average (39.9), the stock would be worth $59.08 (0% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-73%
Maximum Upside
No Upside Scenarios
Average Downside
18%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 39.9 $59.08
0%
3-Year Average 39.9 $59.08
0%
5-Year Average 39.9 $59.08
0%
Industry Average 39.9 $59.08
0%
Country Average 10.9 $16.2
-73%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
DK
Novozymes A/S
OTC:NVZMY
165.6B USD 39.9 54.8
US
Sherwin-Williams Co
NYSE:SHW
80.3B USD 23.3 31.3
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
13.3T JPY 17.1 27.3
US
Ecolab Inc
NYSE:ECL
75.3B USD 25.5 36.3
JP
Yasuhara Chemical Co Ltd
TSE:4957
10.8T JPY 9.3 10.5
CN
Wanhua Chemical Group Co Ltd
SSE:600309
280.1B CNY 7.1 21.3
CH
Givaudan SA
SIX:GIVN
26B CHF 17.2 24.2
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.4T INR 39.3 61.2
US
PPG Industries Inc
NYSE:PPG
24.1B USD 12.4 15.3
US
Albemarle Corp
NYSE:ALB
22B USD 17.2 -32.5
CH
Sika AG
F:SIKA
19.9B EUR 10.7 17.5
P/E Multiple
Earnings Growth PEG
DK
Novozymes A/S
OTC:NVZMY
Average P/E: 30
54.8
N/A N/A
US
Sherwin-Williams Co
NYSE:SHW
31.3
14%
2.2
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
27.3
7%
3.9
US
Ecolab Inc
NYSE:ECL
36.3
14%
2.6
JP
Y
Yasuhara Chemical Co Ltd
TSE:4957
10.5
N/A N/A
CN
Wanhua Chemical Group Co Ltd
SSE:600309
21.3
10%
2.1
CH
Givaudan SA
SIX:GIVN
24.2
6%
4
IN
Asian Paints Ltd
NSE:ASIANPAINT
61.2
15%
4.1
US
PPG Industries Inc
NYSE:PPG
15.3
10%
1.5
US
Albemarle Corp
NYSE:ALB
Negative Multiple: -32.5 N/A N/A
CH
Sika AG
F:SIKA
17.5
8%
2.2

Market Distribution

Lower than 78% of companies in Denmark
Percentile
22nd
Based on 393 companies
22nd percentile
5.8
Low
1.1 — 7.9
Typical Range
7.9 — 18.5
High
18.5 —
Distribution Statistics
Denmark
Min 1.1
30th Percentile 7.9
Median 10.9
70th Percentile 18.5
Max 4 450

Novozymes A/S
Glance View

Market Cap
27.4B USD
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NVZMY Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett